FN1 and nonpapillary renal cell carcinoma: Studies in a model of glioblastoma have shown that tenascin C promotes proliferation and reduces cell adhesion by reducing the binding of fibronectin to its receptor syndecan 4, suggesting a cell biological mechanism for clinical correlation in ccRCC [89].